UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date
of earliest event reported):

(Exact Name of Registrant as Specified in Its Charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
|
|
||
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s
Telephone Number, Including Area Code: (
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
As previously disclosed, on October 28, 2026, Enovix Corporation, a Delaware corporation (the “Company”), announced that the Board of Directors of the Company declared a distribution (the “Warrant Distribution”) to the holders of record of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), in the form of warrants to purchase shares of Common Stock (the “Warrants”). The Warrants were issued on the terms and conditions described in the Warrant Agreement (as defined below and attached as an exhibit hereto) and are being distributed on November 18, 2026, to the holders of record of Common Stock as of the close of business on November 13, 2026 (the “Record Date”).
Pursuant to the terms of the Warrant Agreement, dated as of November 18, 2026, between the Company, Computershare Inc., a Delaware corporation, and its affiliate, Computershare Trust Company, N.A., as Warrant Agent (the “Warrant Agent”) (such agreement, the “Warrant Agreement”), each holder of record of Common Stock as of the Record Date will receive one Warrant for every four shares of Common Stock (rounded down to the nearest whole number for any fractional Warrant). Holders (“other eligible recipients”) of our 3.00% Convertible Senior Notes due 2028 (the “2028 Notes”) and the Company’s 4.75% Convertible Senior Notes due 2030 (collectively with the 2028 Notes, the “Convertible Notes”) will also receive, at the same time and on the same terms as holders of Common Stock, Warrants without having to convert such other eligible recipient’s Convertible Notes as if each such holder of Convertible Notes held a number of shares of Common Stock equal to the product of (i) the conversion rate applicable to the Convertible Notes in effect on the Record Date, and (ii) the aggregate principal amount (expressed in thousands) of Convertible Notes held by such noteholder on such date.
Each Warrant will entitle the holder to purchase, at the holder’s sole and exclusive election, at an exercise price of $3.00 per Warrant (the “Warrant Exercise Price”), one share of Common Stock payable in cash. The Warrants may also be exercised, at the election of the holder, by delivery of certain issued and outstanding notes that may be designated by the Company from time to time pursuant to the terms of the Warrant Agreement (the “Designated Notes”) by delivering an amount equal to $1,000 principal amount of Designated Notes to exercise up to 333 Warrants (subject to certain adjustments). The Company has initially designated the 2028 Notes as Designated Notes.
Unless the Early Expiration Price Condition (defined below) is met, the Warrants will expire and cease to be exercisable at 5:00 p.m. New York City time on the date (the “Expiration Date”) which is (i) April 28, 2028 or (ii) if the Early Expiration Price Condition occurs, the Early Expiration Date, where “Early Expiration Date” means either (x) the first Scheduled Trading Day (defined below) immediately following the Early Expiration Price Condition Date (defined below) (subject to the terms of the Warrant Agreement) (the “Scheduled Early Expiration Date”) or (y) if the Company elects to set an Alternate Early Expiration Date (defined below), such Alternate Early Expiration Date.
Upon the occurrence of the first 30 consecutive Trading Day (defined below) period (the “Reference Period”) that includes 20 Qualifying Trading Days (defined below) (whether or not consecutive) the first of which 20 Qualifying Trading Days must fall on or after the first Trading Day immediately following the distribution date of the Warrants (the “Early Expiration Price Condition”, and the last of such 20 Qualifying Trading Days (whether or not consecutive) to occur, the “Early Expiration Price Condition Date”), the Expiration Date will automatically accelerate to the Scheduled Early Expiration Date, unless the Company sets an Alternate Early Expiration Date (defined below) in accordance with the provisions described below and as further described in the Warrant Agreement, in which case the Early Expiration Date will be such Alternate Early Expiration Date. In the event of an early expiration of the Warrants, Warrants will be exercisable until 5:00 p.m. New York City time on the Early Expiration Date. If the Early Expiration Price Condition occurs, the Company will make a public announcement by issuance of a press release to that effect as promptly as practicable after market close on the Early Expiration Price Condition Date setting forth the Early Expiration Date or an Alternate Early Expiration Date. Subject to applicable laws and regulations and the terms of the Warrant Agreement, including the occurrence of the Early Expiration Price Condition or the Additional Price Conditions (defined below), the Warrants may be exercised at any time starting on the date of issuance until 5:00 p.m. New York City time on the Expiration Date.
1
The Company may, in its sole discretion, elect to set the Early Expiration Date on a Scheduled Trading Day falling after the Scheduled Early Expiration Date (such date, an “Alternate Early Expiration Date”). In order to exercise the right to set an Alternate Early Expiration Date, the Company shall, no later than the fifth Qualifying Trading Day (whether or not consecutive) occurring in any 20 consecutive Trading Day period ending on or before the next following Early Expiration Price Condition Date (if any), make a public announcement by issuance of a press release that the Company is reserving the right to set an Alternate Early Expiration Date in the event the Early Expiration Price Condition does occur. If the Company sets an Alternate Early Expiration Date, the expiration of the Warrants on such Alternate Early Expiration Date shall be conditioned on (x) in respect of each of the two consecutive Scheduled Trading Days immediately preceding such Alternate Early Expiration Date, no Market Disruption Event (as defined in the Warrant Agreement) occurring and (y) the Daily VWAP (defined below) on each of such two consecutive Scheduled Trading Days immediately preceding such Alternate Early Expiration Date being at least equal to the quotient obtained by dividing the Warrant Exercise Price by the then-current Warrant Exercise Rate (as defined in the Warrant Agreement) (the “Additional Price Conditions”). As promptly as practicable after close on the Scheduled Trading Day immediately preceding the Alternate Early Expiration Date, the Company will make a public announcement by issuance of a press release as to whether the Additional Price Conditions are met. The Company may, in its sole discretion, postpone such Alternate Early Expiration Date to a new Alternate Early Expiration Date (which, for the avoidance of doubt, shall be conditional upon the Additional Price Conditions in respect of the Alternate Early Expiration Date so postponed). The Company may, in its sole discretion, postpone further (on one or more occasions) such Alternate Early Expiration Date of the Warrants to a new Alternate Early Expiration Date (which, for the avoidance of doubt, shall be conditional upon the Additional Price Conditions with respect to the Alternate Early Expiration Date as so postponed). The Company will make a public announcement of any such postponement by issuance of a press release as promptly as practicable after the close of regular market hours of Nasdaq on the Scheduled Trading Day immediately preceding the Alternate Early Expiration Date to be so postponed. If the Additional Price Conditions are not met as to an Alternate Early Expiration Date specified by the Company, unless the Company sets a new Alternate Early Expiration Date as set forth in the preceding paragraph (an “Alternate Early Expiration Date Annulment”), the Expiration Date will remain April 28, 2028 unless another Early Expiration Price Condition Date subsequently occurs. The definitions of Early Expiration Price Condition, Early Expiration Price Condition Date and Reference Period are subject to appropriate adjustment as set forth in the Warrant Agreement in the event of an Alternate Early Expiration Date Annulment.
All or any part of the Warrants may be exercised prior to 5:00 p.m. New York City time on the Expiration Date (as it may be adjusted) by delivering to the Warrant Agent a duly executed notice of election and the Warrants being exercised, and payment of the Warrant Exercise Price in cash or, if there are Designated Notes, by delivery of Designated Notes.
For the purposes of the foregoing, “Daily VWAP” of a share of Common Stock (or a Warrant or other security) on any date of determination means (i) in the case of a share of Common Stock, for any day on which trading in the Common Stock generally occurs on the Nasdaq Global Select Market (the “Exchange”) (or, if the Common Stock is not listed on the Exchange, the U.S. national or regional securities exchange or association or over-the-counter market that is the primary market for the trading of the Common Stock on such day), the per-share volume-weighted average price in the consolidated tape system during regular market hours as displayed under the headings “Calculation: Bloomberg” and “VWAP” on Bloomberg page “ENVX US Equity AQR” (or its equivalent successor if such page or setting is not available) in respect of such day, (ii) in the case of a Warrant, for any day on which trading in the Warrant generally occurs on the Exchange (or, if the Warrant is not listed on the Exchange, the U.S. national or regional securities exchange or association or over-the-counter market that is the primary market for the trading of the Warrants on such day), the per-warrant volume-weighted average price in the consolidated tape system during regular market hours as displayed under the headings “Calculation: Bloomberg” and “VWAP” on Bloomberg page “ENVXW US Equity AQR” (or its equivalent successor if such page is not available) in respect of such day, and (iii) in the case of any other security, for any day on which trading in such security generally occurs on the Exchange (or, if the security is not listed on the Exchange, the U.S. national or regional securities exchange or association or over-the-counter market that is the primary market for the trading of such security on such day), the per-share volume-weighted average price in the consolidated tape system during regular market hours as displayed on Bloomberg page “AQR” for such security in respect of such day. If such information is not so available for the Common Stock or such Warrant or other security, the Daily VWAP on such date shall be the last reported sale price for the Common Stock or such Warrant or other security on such day.
2
A “Trading Day” for the purposes of the foregoing definition means a day on which the Common Stock (or Warrant or other security, as the case may be) (i) at the close of regular way trading (not including after-hours or extended market trading) is not suspended from trading on the Exchange or, if the Common Stock (or Warrant or such other security, as the case may be) is not listed on the Exchange, any U.S. national or regional securities exchange or association or over-the-counter market that is the primary market for the trading of the Common Stock (or Warrant or such other security, as the case may be) at the close of business, and (ii) has traded at least once regular way on the Exchange or, if the Common Stock (or Warrant or such other security, as the case may be) is not listed on the Exchange, such other U.S. national securities exchange or association or over-the-counter market that is the primary market for the trading of the Common Stock (or Warrant or such other security, as the case may be); provided that if the Common Stock (or Warrant or such other security, as the case may be) is not so listed or traded, “Trading Day” means a Business Day (as defined in the Warrant Agreement).
A “Qualifying Trading Day” for purposes of the foregoing means any S+W Trading Day (defined below) on which the Daily VWAP of the Common Stock on such Trading Day is at least equal to the Early Expiration Trigger Price (defined below) in effect on the last day of the Reference Period (subject to the conditions and limitations set forth in the Warrant Agreement). An “S+W Trading Day” means any day which is a Trading Day for both the Common Stock and the Warrants.
A “Scheduled Trading Day” means a day that is scheduled to be a Trading Day on the principal U.S. national or regional securities exchange on which the Common Stock is listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange, the principal market on which the Common Stock is admitted for trading. If the Common Stock is not so listed or admitted for trading, “Scheduled Trading Day” means a Business Day.
The “Early Expiration Trigger Price” is initially equal to $3.30, subject to certain adjustments.
The number of shares of Common Stock issuable upon exercise of the Warrants is subject to certain anti-dilution adjustments, including for stock dividends, splits, subdivisions, reclassifications and combinations, other distributions and spin-offs, and shareholder rights plans. In addition, the Warrant Exercise Rate may be voluntarily increased by the Company from time to time.
The Warrants are expected to commence trading on the Nasdaq Stock Market LLC under the ticker “ENVXW” on November 19, 2026.
The foregoing description of the Warrants and the Warrant Agreement is only a summary and is qualified in its entirety by reference to the complete description of the terms of the Warrants set forth in the Warrant Agreement (including the Form of Warrant attached thereto), which is filed as an exhibit to this Form 8-K. In connection with the Warrant Distribution, the Company is filing a prospectus supplement, dated November 18, 2026, pursuant to the Company’s existing shelf registration statement on Form S-3, declared effective on November 9, 2026, registering up to $500,000,000 of shares of Common Stock, including the shares of Common Stock to be issued upon exercise of the Warrants, under the Securities Act of 1933, as amended (the “Securities Act”).
3
Item 7.01 Regulation FD Disclosure.
On November 18, 2026, the “Company” issued a press release announcing the Warrant Distribution to its shareholders and other eligible recipients as of the November 13, 2026 Record Date. The press release is attached as Exhibit 99.1 to this Form 8-K.
Also on November 18, 2026, the Company posted a further FAQ regarding the Warrant Distribution to the Company’s website (the “FAQ”). The FAQ is attached as Exhibit 99.2 to this Form 8-K. The Company previously announced the Warrant Distribution on October 28, 2026 and published an initial set of questions and answers on its website, which was furnished as Exhibit 99.2 to the Company’s Form 8-K filed on October 28, 2026.
The information furnished in this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such filing.
No Offer or Solicitation
This communication shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. A Form 8-A registration statement and prospectus supplement describing the terms of the Warrants were filed with the Securities and Exchange Commission (the “SEC”) on November 18, 2026 and are available on the SEC’s website located at http://www.sec.gov. Holders of Company common stock should read the prospectus supplement carefully, including the Risk Factors section included and incorporated by reference therein. This communication contains a general summary of the Warrants. Please read the Warrant Agreement as it contains important information about the terms of the Warrants.
Forward-Looking Statements
This Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act about the Company, the Warrants and the Warrant Distribution. Forward-looking statements generally relate to future events and can be identified by words such as anticipate, believe, continue, could, estimate, expect, intend, may, might, plan, possible, potential, predict, should, would and similar expressions that convey uncertainty about future events or outcomes. Actual results and outcomes could differ materially from these forward-looking statements as a result of certain risks and uncertainties, including, without limitation, those risks and uncertainties and other potential factors set forth in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed annual report on Form 10-K and quarterly reports on Form 10-Q and other documents that the Company has filed, or that it will file, with the SEC. Any forward-looking statements made by the Company in this Form 8-K, including any forward-looking statements made by the Company in any of the exhibits to this Form 8-K, speak only as of the date on which they are made and subsequent events may cause these expectations to change. The Company disclaims any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise, except as required by law.
4
Item 9.01 Financial Statements and Exhibits.
On November 18, 2026, Arnold & Porter Kaye Scholer LLP delivered an opinion (the “Opinion”) to the Company in connection with the Company’s issuance of up to 62,329,657 shares of Common Stock upon exercise of the Warrants. Such shares will be issued pursuant to the Company’s shelf registration statement on Form S-3 (No. 333-299760) (the “Registration Statement”), which was declared effective on November 9, 2026, including the prospectus, dated November 9, 2026, and the prospectus supplement, dated November 18, 2026, as the same may be amended or supplemented. The Opinion is being filed herewith as Exhibit 5.1, and thereby automatically incorporated by reference into the Registration Statement, in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.
(d) Exhibits
| Exhibit Number | Description | |
| 4.1 | Warrant Agreement (including Form of Warrant), dated November 18, 2026, between the Company, Computershare Inc., a Delaware corporation, and Computershare Trust Company, N.A., as Warrant Agent. | |
| 5.1 | Opinion of Arnold & Porter Kaye Scholer LLP | |
| 23.1 | Consent of Arnold & Porter Kaye Scholer LLP (included in Exhibit 5.1). | |
| 99.1 | Press Release dated November 18, 2026 | |
| 99.2 | Warrant Dividend Distribution FAQ dated November 18, 2026 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
5
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Enovix Corporation | ||
| Date: November 18, 2026 | By: | /s/ Ryan Benton |
| Ryan Benton Interim Chief Executive Officer and Chief Financial Officer | ||
6